Cord-blood respiratory syncytial virus antibodies and respiratory health in first 5 years of life

To determine the potential longer-term effects of maternal antenatal respiratory syncytial virus (RSV) vaccination, we examined the association between cord-blood RSV-neutralizing antibodies (RSV-NA) and RSV infections in the first 2 years of life, RSV-NA at 3 years, and respiratory health to age 5 years.

Citation:
Takashima MD, Grimwood K, Sly PD, Lambert SB, Kusel M, Holt B, Holt P… et al. Cord-blood respiratory syncytial virus antibodies and respiratory health in first 5 years of life. Pediatric Pulmonology. 2021.

Keywords:
Asthma; child; cord-blood antibodies; respiratory syncytial virus

Abstract:
To determine the potential longer-term effects of maternal antenatal respiratory syncytial virus (RSV) vaccination, we examined the association between cord-blood RSV-neutralizing antibodies (RSV-NA) and RSV infections in the first 2 years of life, RSV-NA at 3 years, and respiratory health to age 5 years.